… silico approach is carried out as a means of inhibiting the spike protein of the novel coronavirus
… that are docked with the spike protein of SARS-CoV-2, to determine the highest binding …

… towards SARS-CoV-2. Therefore, in the current investigation attempt has been made to …
and evaluate the potency of different Saikosaponins against different sets of SARS-CoV-2 …

… of SARS-CoV-2 spike protein into the lung tissue [5,6]. Many studies have revealed the crystal
structures of the main protease of SARS CoV-… To design novel drugs against SARS CoV-2, …

… novel coronavirus, called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
The nonstructural protein 16 (NSP16) of SARS-CoV-2 plays a significant part in the …

… for the treatment of SARS-CoV-2 [5,6]. Both drugs were proposed as promising agents for
the treatment of SARS-CoV-1 by an in silico study conducted in 2016 which had evaluated the …

… study, this was performed in silico for 11 primers and probe sets using the bioinformatics
tool SCREENED and 84,305 representative SARS-CoV-2 genomes obtained from GISAID and …

… human infectious coronavirus that … silico drug discovery tools were utilized to evaluate
the binding affinities and features of eighteen anti-COVID-19 drug candidates against SARS-CoV-…

… Our in-silico analysis proved that natural antioxidants like sesamin, ellagic acid, epicatechin
… most vital active site residue Cys145 of SARS-CoV-2 main protease with great significance …

… of the SARS-CoV-2 M pro and RBD receptors. The synthesis of these molecules and evaluation
of their in vitro and in vivo activity against SARS-CoV-2 is worthy of further clinical study. …

… , already documented 51,52 , have not been considered in the present study, and may
deserve a future specific in silico evaluation followed by a possible experimental validation. …